beta-lapachone has been researched along with B16 Melanoma in 1 studies
beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase
beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lamberti, MJ | 1 |
| Morales Vasconsuelo, AB | 1 |
| Chiaramello, M | 1 |
| Ferreira, VF | 1 |
| Macedo Oliveira, M | 1 |
| Baptista Ferreira, S | 1 |
| Rivarola, VA | 1 |
| Rumie Vittar, NB | 1 |
1 other study available for beta-lapachone and B16 Melanoma
| Article | Year |
|---|---|
NQO1 induction mediated by photodynamic therapy synergizes with β-Lapachone-halogenated derivative against melanoma.
Topics: Animals; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Humans; Melanoma, Experi | 2018 |